Vernal Biosciences, Inc.

Colchester, VT · Founded 2020 · CIK 0001861147 · Biotech · Private

mRNA manufacturing platform with LNP formulation and GMP support services for therapeutic production

vernal.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$22M
2 Form D · May 2022
53 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,500,000
Private capital raisedForm D · SEC$20,998,407
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3360ALPHAMEMORY, LLC——
3361CORMEDIX, INC.—$3.5M
3362ACTINOBAC BIOMED, INC.—$3.4M
3363Vernal Biosciences, Inc.—$22M
3364AVICANNA INC.—$10M
3365Adipo Therapeutics, LLC—$6.0M
3366Adcendo——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • David AndersonDirector
  • Errik AndersonDirector
  • Christian CobaughDirector · Executive Officer
  • Daniella KranjacDirector
  • Gustavo MahlerDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.